The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schmidt, C. S.
Right arrow Articles by Mescher, M. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schmidt, C. S.
Right arrow Articles by Mescher, M. F.
Right arrowPubmed/NCBI databases
*Substance via MeSH
The Journal of Immunology, 2002, 168: 5521-5529.
Copyright © 2002 by The American Association of Immunologists

Peptide Antigen Priming of Naive, But Not Memory, CD8 T Cells Requires a Third Signal That Can Be Provided by IL-121

Clint S. Schmidt2 and Matthew F. Mescher3

Center for Immunology, Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455

Challenge with peptide Ag in the absence of adjuvant results in tolerance of CD8 T cells specific for the Ag. In contrast, administration of IL-12 along with peptide results in massive clonal expansion, development of effector function, and establishment of a long-lived memory population. Using adoptive transfer of TCR-transgenic CD8 T cells, this effect of IL-12 is shown to be independent of CD4 T cells and to require costimulation provided by CD28 and possibly LFA-1. IL-12 supports responses when IL-12R{beta}1-deficient mice are used as recipients for the adoptively transferred CD8 T cells, demonstrating that the IL-12 is acting directly on the T cells rather than on host APC. These results provide strong support for a three-signal model for in vivo activation of naive CD8 T cells by peptide Ag, in which the presence or absence of the third signal determines whether tolerance or activation occurs. In contrast, memory CD8 T cells are effectively activated by peptide Ag in the absence of IL-12 or adjuvant.




This article has been cited by other articles:


Home page
J. Immunol.Home page
P. Agarwal, A. Raghavan, S. L. Nandiwada, J. M. Curtsinger, P. R. Bohjanen, D. L. Mueller, and M. F. Mescher
Gene Regulation and Chromatin Remodeling by IL-12 and Type I IFN in Programming for CD8 T Cell Effector Function and Memory
J. Immunol., August 1, 2009; 183(3): 1695 - 1704.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. D. Kuns, E. S. Morris, K. P. A. MacDonald, K. A. Markey, H. M. Morris, N. C. Raffelt, T. Banovic, A. L. J. Don, V. Rowe, A. C. Burman, et al.
Invariant natural killer T cell-natural killer cell interactions dictate transplantation outcome after {alpha}-galactosylceramide administration
Blood, June 4, 2009; 113(23): 5999 - 6010.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Kovar, J. Tomala, H. Chmelova, L. Kovar, T. Mrkvan, R. Joskova, Z. Zakostelska, T. Etrych, J. Strohalm, K. Ulbrich, et al.
Overcoming Immunoescape Mechanisms of BCL1 Leukemia and Induction of CD8+ T-Cell-Mediated BCL1-Specific Resistance in Mice Cured by Targeted Polymer-Bound Doxorubicin
Cancer Res., December 1, 2008; 68(23): 9875 - 9883.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Q. Zhu, C. Egelston, A. Vivekanandhan, S. Uematsu, S. Akira, D. M. Klinman, I. M. Belyakov, and J. A. Berzofsky
Toll-like receptor ligands synergize through distinct dendritic cell pathways to induce T cell responses: Implications for vaccines
PNAS, October 21, 2008; 105(42): 16260 - 16265.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. D. Hammerbeck and M. F. Mescher
Antigen Controls IL-7R{alpha} Expression Levels on CD8 T Cells during Full Activation or Tolerance Induction
J. Immunol., February 15, 2008; 180(4): 2107 - 2116.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
V. A. Love, N. Grabie, P. Duramad, G. Stavrakis, A. Sharpe, and A. Lichtman
CTLA-4 Ablation and Interleukin-12 Driven Differentiation Synergistically Augment Cardiac Pathogenicity of Cytotoxic T Lymphocytes
Circ. Res., August 3, 2007; 101(3): 248 - 257.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. A. Casey and M. F. Mescher
IL-21 Promotes Differentiation of Naive CD8 T Cells to a Unique Effector Phenotype
J. Immunol., June 15, 2007; 178(12): 7640 - 7648.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. M. Curtsinger, M. Y. Gerner, D. C. Lins, and M. F. Mescher
Signal 3 Availability Limits the CD8 T Cell Response to a Solid Tumor
J. Immunol., June 1, 2007; 178(11): 6752 - 6760.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
Y. Peng, H. Shao, Y. Ke, P. Zhang, G. Han, H. J. Kaplan, and D. Sun
Minimally Activated CD8 Autoreactive T Cells Specific for IRBP Express a High Level of Foxp3 and Are Functionally Suppressive
Invest. Ophthalmol. Vis. Sci., May 1, 2007; 48(5): 2178 - 2184.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. S. Way, C. Havenar-Daughton, G. A. Kolumam, N. N. Orgun, and K. Murali-Krishna
IL-12 and Type-I IFN Synergize for IFN-{gamma} Production by CD4 T Cells, Whereas Neither Are Required for IFN-{gamma} Production by CD8 T Cells after Listeria monocytogenes Infection
J. Immunol., April 1, 2007; 178(7): 4498 - 4505.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Barbey, P. Baumgaertner, E. Devevre, V. Rubio-Godoy, L. Derre, G. Bricard, P. Guillaume, I. F. Luescher, D. Lienard, J.-C. Cerottini, et al.
IL-12 Controls Cytotoxicity of a Novel Subset of Self-Antigen-Specific Human CD28+ Cytolytic T Cells
J. Immunol., March 15, 2007; 178(6): 3566 - 3574.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. M. Gray, S. L. Reiner, D. F. Smith, P. M. Kaye, and P. Scott
Antigen-Experienced T Cells Limit the Priming of Naive T Cells during Infection with Leishmania major
J. Immunol., July 15, 2006; 177(2): 925 - 933.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
A. Jabbari and J. T. Harty
The generation and modulation of antigen-specific memory CD8 T cell responses
J. Leukoc. Biol., July 1, 2006; 80(1): 16 - 23.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Peng, H. Shao, Y. Ke, P. Zhang, J. Xiang, H. J. Kaplan, and D. Sun
In Vitro Activation of CD8 Interphotoreceptor Retinoid-Binding Protein-Specific T Cells Requires not only Antigenic Stimulation but also Exogenous Growth Factors.
J. Immunol., April 15, 2006; 176(8): 5006 - 5014.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. M. Curtsinger, D. C. Lins, C. M. Johnson, and M. F. Mescher
Signal 3 Tolerant CD8 T Cells Degranulate in Response to Antigen but Lack Granzyme B to Mediate Cytolysis
J. Immunol., October 1, 2005; 175(7): 4392 - 4399.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. A. Markiewicz, L. N. Carayannopoulos, O. V. Naidenko, K. Matsui, W. R. Burack, E. L. Wise, D. H. Fremont, P. M. Allen, W. M. Yokoyama, M. Colonna, et al.
Costimulation through NKG2D Enhances Murine CD8+ CTL Function: Similarities and Differences between NKG2D and CD28 Costimulation
J. Immunol., September 1, 2005; 175(5): 2825 - 2833.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. A. Filatenkov, E. L. Jacovetty, U. B. Fischer, J. M. Curtsinger, M. F. Mescher, and E. Ingulli
CD4 T Cell-Dependent Conditioning of Dendritic Cells to Produce IL-12 Results in CD8-Mediated Graft Rejection and Avoidance of Tolerance
J. Immunol., June 1, 2005; 174(11): 6909 - 6917.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. S. Kang and P. M. Allen
Priming in the Presence of IL-10 Results in Direct Enhancement of CD8+ T Cell Primary Responses and Inhibition of Secondary Responses
J. Immunol., May 1, 2005; 174(9): 5382 - 5389.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. O. Valenzuela, C. D. Hammerbeck, and M. F. Mescher
Cutting Edge: Bcl-3 Up-Regulation by Signal 3 Cytokine (IL-12) Prolongs Survival of Antigen-Activated CD8 T Cells
J. Immunol., January 15, 2005; 174(2): 600 - 604.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. V. Gorbachev and R. L. Fairchild
CD40 Engagement Enhances Antigen-Presenting Langerhans Cell Priming of IFN-{gamma}-Producing CD4+ and CD8+ T Cells Independently of IL-12
J. Immunol., August 15, 2004; 173(4): 2443 - 2452.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Th. den Boer, G. J. D. van Mierlo, M. F. Fransen, C. J. M. Melief, R. Offringa, and R. E. M. Toes
The Tumoricidal Activity of Memory CD8+ T Cells Is Hampered by Persistent Systemic Antigen, but Full Functional Capacity Is Regained in an Antigen-Free Environment
J. Immunol., May 15, 2004; 172(10): 6074 - 6079.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. L. Salem, A. N. Kadima, Y. Zhou, C. L. Nguyen, M. P. Rubinstein, M. Demcheva, J. N. Vournakis, D. J. Cole, and W. E. Gillanders
Paracrine Release of IL-12 Stimulates IFN-{gamma} Production and Dramatically Enhances the Antigen-Specific T Cell Response after Vaccination with a Novel Peptide-Based Cancer Vaccine
J. Immunol., May 1, 2004; 172(9): 5159 - 5167.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. D. Anthony, N. L. Yonkers, A. B. Post, R. Asaad, F. P. Heinzel, M. M. Lederman, P. V. Lehmann, and H. Valdez
Selective Impairments in Dendritic Cell-Associated Function Distinguish Hepatitis C Virus and HIV Infection
J. Immunol., April 15, 2004; 172(8): 4907 - 4916.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. M. Richards, S. L. Dalheimer, B. D. Ehst, T. L. Vanasek, M. K. Jenkins, M. I. Hertz, and D. L. Mueller
Indirect Minor Histocompatibility Antigen Presentation by Allograft Recipient Cells in the Draining Lymph Node Leads to the Activation and Clonal Expansion of CD4+ T Cells That Cause Obliterative Airways Disease
J. Immunol., March 15, 2004; 172(6): 3469 - 3479.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Chang, J.-H. Cho, S.-W. Lee, S.-Y. Choi, S.-J. Ha, and Y.-C. Sung
IL-12 Priming during In Vitro Antigenic Stimulation Changes Properties of CD8 T Cells and Increases Generation of Effector and Memory Cells
J. Immunol., March 1, 2004; 172(5): 2818 - 2826.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S.-J. Ha, D.-J. Kim, K.-H. Baek, Y.-D. Yun, and Y.-C. Sung
IL-23 Induces Stronger Sustained CTL and Th1 Immune Responses Than IL-12 in Hepatitis C Virus Envelope Protein 2 DNA Immunization
J. Immunol., January 1, 2004; 172(1): 525 - 531.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. M. Curtsinger, C. M. Johnson, and M. F. Mescher
CD8 T Cell Clonal Expansion and Development of Effector Function Require Prolonged Exposure to Antigen, Costimulation, and Signal 3 Cytokine
J. Immunol., November 15, 2003; 171(10): 5165 - 5171.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
J. Liu, C. S. Schmidt, F. Zhao, A. J. Okragly, A. Glasebrook, N. Fox, E. Galbreath, Q. Zhang, H. Y. Song, S. Na, et al.
LIGHT-deficiency impairs CD8+ T cell expansion, but not effector function
Int. Immunol., July 1, 2003; 15(7): 861 - 870.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
J. M. Curtsinger, D. C. Lins, and M. F. Mescher
Signal 3 Determines Tolerance versus Full Activation of Naive CD8 T Cells: Dissociating Proliferation and Development of Effector Function
J. Exp. Med., May 5, 2003; 197(9): 1141 - 1151.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Goldberg, P. Shrikant, and M. F. Mescher
In Vivo Augmentation of Tumor-Specific CTL Responses by Class I/Peptide Antigen Complexes on Microspheres (Large Multivalent Immunogen)
J. Immunol., January 1, 2003; 170(1): 228 - 235.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Valenzuela, C. Schmidt, and M. Mescher
The Roles of IL-12 in Providing a Third Signal for Clonal Expansion of Naive CD8 T Cells
J. Immunol., December 15, 2002; 169(12): 6842 - 6849.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.